Source: 5th Sleep and Breathing Conference



Rating:

Share or cite this content

Citations should be made in the following way:
Marie Marklund. Exploring fully digitised pathways to optimize MRD treatment. 5th Sleep and Breathing Conference

Member's Comments

No comment yet.

Related content which might interest you: How to better assess and predict disease progression and treatment response: home-based spirometry, biomarkers or …? Source: International Congress 2019 – High-tech in interstitial lung diseases: just hype and gadgets? Year: 2019 Long COVID: to investigate immunological mechanisms and sex/gender related aspects as fundamental steps for tailored therapy Source: Eur Respir J, 59 (2) 2102245; 10.1183/13993003.02245-2021 Year: 2022 Population segmentation to identify priority targets for identification and behaviour change interventions in COPD Source: Annual Congress 2011 - Disease management in specific primary care populations Year: 2011 On the temporal characterisation of novel capnometric indices for personalised monitoring and treatment optimisation of COPD Source: International Congress 2019 – Insights into physiological diagnostic services Year: 2019 A combinational approach to optimize biomarkers efficacy in identifying patients with sarcoidosis and monitoring respiratory functional worsening Source: Annual Congress 2012 - Diffuse parenchymal lung disease IV Year: 2012 What do we need in the clinic and what approach can clinicians take to improve the drug development pipeline? Source: ERS Research Seminar 2016 Year: 2016 Digital approaches to promote adherence to treatments and patient education Source: Virtual Congress 2021 – Virtual/multimodal education, communication skills Year: 2021 Individualised field testing is a useful tool to evaluate difficult asthma. Source: International Congress 2017 – Diagnostic tools and comorbidities in paediatric asthma Year: 2017 Developing a new ultrasonic method to assess diaphragm movement and comparing the accuracy with existing methods. Source: International Congress 2017 – Respiratory muscles: evaluation and pathophysiology Year: 2017 COPD biomarkers and phenotypes: opportunities for better outcomes with precision imaging Source: Eur Respir J, 52 (5) 1801570; 10.1183/13993003.01570-2018 Year: 2018 Using qualitative methods to explore the implementation of diagnostics in primary care Source: Value-Dx event 2019: VALUE-Dx kick off meeting and course Year: 2019 Harnessing digital technology to improve the lives of patients with respiratory disease Source: International Congress 2019 – Harnessing digital technology to improve the lives of patients with respiratory disease Year: 2019 Ensuring rational introduction and responsible use of new TB tools: outcome of an ERS multisector consultation Source: Eur Respir J 2014; 44: 1412-1417 Year: 2014 Integration at the network- and pathway level of multi-omics data from multiple anatomical locations facilitate COPD sub-phenotyping in small cohorts Source: International Congress 2017 – Novel molecular and genetic targets in COPD Year: 2017 What are the optimum signals to include in a portable monitor? Source: Annual Congress 2008 - Portable monitoring for sleep apnoea: the way forward? Year: 2008 Identifying tools to investigate outcomes following an exacerbation of COPD Source: International Congress 2019 – Airway disease-associated exacerbations Year: 2019 Fitness for radical treatment modalities: efficient functional assessment, improving fitness and fitness-adapted therapy concepts including the elderly Source: International Congress 2017 – PG1 Re-defining the role of chest physicians in lung cancer: new opportunities in diagnostics and therapy Year: 2017 Clinical feasibility study utilizing multi-sensor devices with the goal of developing remote monitoring digital health solutions for patients with asthma or COPD Source: Virtual Congress 2020 – Digital health interventions in respiratory medicine Year: 2020 Non-targeted integrative multi-omics approaches on sputum reveal potential diagnostic and monitoring biomarkers for respiratory diseases Source: International Congress 2017 – Novel molecular and genetic targets in COPD Year: 2017